ZD-4190

CAS No. 413599-62-9

ZD-4190 ( —— )

Catalog No. M20212 CAS No. 413599-62-9

ZD-4190 is a inhibitor of the vascular endothelial cell growth factor receptor 2 (VEGFR2) and of epidermal growth factor receptor (EGFR) signalling used for the treatment of cancer.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 173 In Stock
5MG 290 In Stock
10MG 435 In Stock
25MG 692 In Stock
50MG 945 In Stock
100MG 1278 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    ZD-4190
  • Note
    Research use only not for human use.
  • Brief Description
    ZD-4190 is a inhibitor of the vascular endothelial cell growth factor receptor 2 (VEGFR2) and of epidermal growth factor receptor (EGFR) signalling used for the treatment of cancer.
  • Description
    ZD-4190 is a inhibitor of the vascular endothelial cell growth factor receptor 2 (VEGFR2) and of epidermal growth factor receptor (EGFR) signalling used for the treatment of cancer.
  • Synonyms
    ——
  • Pathway
    Angiogenesis
  • Target
    EGFR
  • Recptor
    EGFR/VEGFR2
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    413599-62-9
  • Formula Weight
    459.28
  • Molecular Formula
    C19H16BrFN6O2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:20.83 mg/mL?(45.35 mM)
  • SMILES
    COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCn1ccnn1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Yang M et al. PET imaging of early response to the tyrosine kinase inhibitor ZD4190. Eur J Nucl Med Mol Imaging. 2011 Jul;38(7):1237-47. doi: 10.1007/s00259-011-1742-z. Epub 2011 Mar 1.
molnova catalog
related products
  • Epimedin B

    Epimedin B has potential activity against osteoporosis by stimulating osteoblasts.

  • AG-1517

    PD153035 hydrochloride is a potent and specific inhibitor of EGFR with Ki and IC50 of 5.2 pM and 29 pM in cell-free assays; little effect noted against PGDFR, FGFR, CSF-1, InsR and Src.

  • Peiminine

    Peiminine is an effective inhibitor for lung inflammation and pulmonary fibrosis in a rat model of bleomycin-induced lung injury.